礼来制药寻求干预美国食品药品管理局与众多配药师之间关于礼来减肥药Tirzepatide是否仍然存在供应短缺问题的官司。礼来称,2024年8月份以来,公司所有药剂都可以获得。礼来认为,美国FDA在官司中有其他意图。

金融界
03 Jan
礼来制药寻求干预美国食品药品管理局与众多配药师之间关于礼来减肥药Tirzepatide是否仍然存在供应短缺问题的官司。礼来称,2024年8月份以来,公司所有药剂都可以获得。礼来认为,美国FDA在官司中有其他意图。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10